1998
Socially desirable response tendency as a correlate of accuracy of self‐reported HIV serostatus for HIV seropositive injection drug users
Latkin C, Vlahov D. Socially desirable response tendency as a correlate of accuracy of self‐reported HIV serostatus for HIV seropositive injection drug users. Addiction 1998, 93: 1191-1197. PMID: 9813900, DOI: 10.1046/j.1360-0443.1998.93811917.x.Peer-Reviewed Original ResearchConceptsSelf-reported HIV serostatusSocial desirabilityInjection drug usersCorrelates of accuracyDesirable response tendenciesHIV serostatusDrug usersResponse tendenciesDesirable respondingHIV-seronegative participantsALIVE studyPredictive validityHIV-seropositive injection drug usersActive injection drug usersLongitudinal studySeropositive injection drug usersPositive predictive value 97Higher scoresHIV-seropositive participantsHIV prevention studyQuestionable validityNegative predictive valueParticipantsSeronegative participantsSeropositive participants
1996
The long‐term outcome of a personal network‐oriented HIV prevention intervention for injection drug users: The SAFE study
Latkin C, Mandell W, Vlahov D, Oziemkowska M, Celentano D. The long‐term outcome of a personal network‐oriented HIV prevention intervention for injection drug users: The SAFE study. American Journal Of Community Psychology 1996, 24: 341-364. PMID: 8864208, DOI: 10.1007/bf02512026.Peer-Reviewed Original ResearchConceptsNeedle sharingSocial influence processesHuman immunodeficiency virus (HIV) risk behaviorsNetwork-oriented interventionMultiple logistic regression modelFrequent needle sharingSharing of cookersHIV-seronegative participantsLong-term outcomesInfluence processesInjection drug usersHIV prevention interventionsSelf-reported behavioral outcomesHealth-related behaviorsLogistic regression modelsALIVE studyExperimental study designSeronegative participantsHIV preventionBaseline interviewPrevention interventionsEpidemiological studiesSignificant negative associationDrug usersPreventive interventions
1995
Temporal Trends of Incident Human Immunodeficiency Virus Infection in a Cohort of Injecting Drug Users in Baltimore, Md
Nelson K, Vlahov D, Solomon L, Cohn S, Muñoz A. Temporal Trends of Incident Human Immunodeficiency Virus Infection in a Cohort of Injecting Drug Users in Baltimore, Md. JAMA Internal Medicine 1995, 155: 1305-1311. PMID: 7778962, DOI: 10.1001/archinte.1995.00430120091011.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virus (HIV) infectionImmunodeficiency virus infectionHuman immunodeficiency virusDrug usersVirus infectionImmunodeficiency virusEffective human immunodeficiency virus (HIV) vaccineHuman immunodeficiency virus risk factorsIncident human immunodeficiency virus (HIV) infectionsHuman immunodeficiency virus (HIV) seroconversionHuman immunodeficiency virus (HIV) antibodyHuman immunodeficiency virus (HIV) vaccinesIllicit drug injectionInjecting Drug UsersHigh-risk populationImmunodeficiency virus vaccinesIncidence of infectionPrevention of infectionSterile injection equipmentEnzyme-linked immunosorbent assaySeronegative participantsStudy clinicAnnual incidenceImmunodeficiency syndromeOverall incidence